Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Good for another year
April 2020
SHARING OPTIONS:

CAMBRIDGE, U.K. & LONDON—A yearlong collaboration between Metrion Biosciences Limited and LifeArc has been renewed for another 12 months to extend through 2020, the companies announced recently. The original term of the deal began in January 2019, and saw the partners identify hit compounds and advance into the hit-to-lead optimization phase. The collaboration is focused on ion channel drug discovery within neuroscience. Per the agreement, LifeArc is responsible for all new chemical syntheses, while Metrion will provide ion channel screening expertise and support target optimization.
 
“The extension of this collaboration is testament to the achievements of the combined team to date, and to our long-standing successful relationship with LifeArc. We are excited to be moving forward for an additional 12 months and progress the project to further advance research in this important field of neuroscience,” commented Dr. Edward Stevens, head of Drug Discovery, Metrion Biosciences.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.